The rise of electronic health records can facilitate the use of decision support systems when ordering and selecting imaging tests. Also, should these tools be mandated?
The rise of electronic health records can facilitate the use of decision support systems when ordering and selecting imaging tests.
That’s according to Steven Seltzer, MD, chairman of the department of radiology at Brigham and Women’s Hospital, who spoke Thursday at The Summit on Management of Radiation Dose in Computerized Tomography at the National Institutes of Health.
EHRs, the use of which is growing thanks to the federal government’s program to offer incentives for EHR adoption, can provide an easy support system for physicians - based on medical evidence and appropriateness data.
“Without an electronic health record, we don’t have this, but now that we’re getting them… we will soon have these tools,” Seltzer said at the summit, which was videocast online. The two-day summit aims to bring together the imaging community to identify steps and research needed to reduce CT exam dose to less than one mSv.
Decision support systems are being explored as tools to reduce unnecessary tests and exposure, and CMS’ two-year Medicare Imaging Demonstration project recently launched to see if the systems are effective.
Using the decision support connected to the EHR can reduce errors, optimize reimbursement by connecting the tests with billing codes, and facilitate the transfer of clinical data and results, Seltzer said.
“All of these things become possible when you move out of the analog era,” he said.
Hedvig Hricak, MD, PhD, chair of the department of radiology at Memorial Sloan-Kettering Cancer Center in New York City and professor of radiology at Cornell University Medical College, argued in her earlier presentation Thursday that decision support tools should be mandatory. It’s time to regulate, she said.
“It should be in every practice,” she said. The problem with computerized decision support systems, she noted, was they must be developed in a multidisciplinary setting, which can be complicated.
“The problem is you’re going to have a relatively easier time implementing them in larger tertiary centers and academic settings, but where it makes a bigger difference is in the community setting and every private physician in this country.”
Decision support was also among the strategies for reducing radiation exposire outlined at the summit by representatives from the American College of Radiology. The group also pointed to ACR accreditation, including basic training and image standards, and a dose index registry, which collects patient dose information and compares against national benchmarks.
"Accreditation, decision support systems and the CT dose registry programs can reduce adverse events, unwarranted radiation exposure and unnecessary cost if Congress would vote to require all imaging providers - including hospitals - to participate in them," John A. Patti, MD, FACR, chair of the ACR Board of Chancellors said in a statement. "Now, when imaging providers and government agencies are coming together to arrive at better imaging policy is the time for Congress to act to require participation in these programs and help ensure quality and safety of medical imaging care."
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.